rel-Lifirafenib
Important Notice: For research use only. We do not sell to patients.
Other Forms of rel-Lifirafenib
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. |
---|
Catalog Num | A20988 |
---|---|
Formula | C25H17F3N4O3 |
Molecular Weight | 478.42 |
CAS Number | 1446090-77-2 |
SMILES | FC(F)(F)C(C=C1)=CC2=C1N=C(N2)[C@@H]3[C@H]([C@@H]43)OC(C4=C5)=CC=C5OC6=CC=NC(N7)=C6CCC7=O |
Synonyms | BGB-283, BGB283, BGB 283 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2